Logo image of NVO

NOVO-NORDISK A/S-SPONS ADR (NVO) Stock Analyst Ratings

NYSE:NVO - New York Stock Exchange, Inc. - US6701002056 - ADR - Currency: USD

69.23  +3.63 (+5.53%)

Premarket: 70.56 +1.33 (+1.92%)

Buy % Consensus

74

ChartMill assigns a Buy % Consensus number of 74% to NVO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 113.73. This target is 64.27% above the current price.
NVO was analyzed by 32 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about NVO.
In the previous month the buy percentage consensus was at a similar level.
NVO was analyzed by 32 analysts, which is quite many. So the average rating should be quite meaningful.
NVO Historical Analyst RatingsNVO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 10 20 30

Price Target & Forecast

Price Low Median Mean High 69.2362.84109.68113.73185.49 - -9.24% 58.43% 64.27% 167.93%
NVO Current Analyst RatingNVO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2025-04-17 BMO Capital Downgrade Outperform -> Market Perform
2025-01-08 UBS Upgrade Sell -> Buy
2024-12-23 BMO Capital Maintains Outperform -> Outperform
2024-11-06 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-10-17 BMO Capital Maintains Outperform -> Outperform
2024-10-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-16 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-19 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-08 BMO Capital Maintains Outperform -> Outperform
2024-08-05 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-01 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-25 BMO Capital Maintains Outperform -> Outperform
2024-06-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-17 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-10 Argus Research Maintains Buy -> Buy
2024-04-18 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-12 BMO Capital Initiate Outperform
2024-04-05 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-01 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-08 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-02-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-02-15 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-02-14 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-02-01 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-01-23 Morgan Stanley Initiate Overweight
2023-12-04 TD Cowen Maintains Outperform -> Outperform
2023-12-01 Cantor Fitzgerald Initiate Overweight